The CRC Blueprint

My scientific approach to my own cancer – shared with you.

Ireland

Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation

Phase 3 · randomised · 461 people · 419 sites in 32 countries · Running, not taking new patients

August 7, 2026
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

Phase 3 · randomised · 400 people · 366 sites in 25 countries · Recruiting now

August 7, 2026